---
title: "Morning Trend | MICROPORT's technical indicators weaken, and the risk of wave-type decline still exists"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282003359.md"
description: "MicroPort Scientific Corporation (853.HK) technical chart shows a clear weak pattern. The daily MACD death cross indicates a slowdown in momentum, with the market approaching the bottom support level but not yet showing a rebound trend. The shrinking trading volume indicates a clear stance of capital waiting and observing. The pharmaceutical sector is under pressure from policy adjustments and a slowdown in overseas market demand, creating pressure on the company's profitability. Future market focus factors include the long-term growth prospects of the industry and changes in the policy environment"
datetime: "2026-04-09T01:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282003359.md)
  - [en](https://longbridge.com/en/news/282003359.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282003359.md)
---

# Morning Trend | MICROPORT's technical indicators weaken, and the risk of wave-type decline still exists

MicroPort Scientific Corporation (853.HK) technical chart shows a clear weak pattern. The daily MACD death cross indicates a slowdown in momentum, with the market approaching bottom support levels but not yet showing a rebound trend. The shrinking trading volume reflects a clear wait-and-see stance from funds. The pharmaceutical sector is under pressure from policy adjustments and a slowdown in overseas market demand, creating challenges for the company's profitability. Future market focus factors include the long-term growth prospects of the industry and changes in the policy environment

### Related Stocks

- [00853.HK](https://longbridge.com/en/quote/00853.HK.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)

## Related News & Research

- [Rapid Medical™ Announces FDA Clearance of TIGERTRIEVER™ 25 and First Clinical Cases](https://longbridge.com/en/news/283017446.md)
- [PTA-Adhoc: Gallmetzer HealthCare S.p.A.: Announcement of the publication of financial reports](https://longbridge.com/en/news/283108240.md)
- [How to Control Portfolio Risk Using Market Groups and Sub-Group Caps](https://longbridge.com/en/news/283229952.md)
- [Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life](https://longbridge.com/en/news/283360869.md)
- [08:01 ETPulsePoint Launches Adaptive Optimization™ Insights, Proving AI‑Driven Campaign Performance with 18% Audience Quality Lift](https://longbridge.com/en/news/283495492.md)